FDA Adverse Event Injury Summary report: N

MITROFLOW AORTIC PERICARDIAL HEART VALVE

MDR report key: 4329720 · Received August 19, 2014

Report

Report Number
3004478276-2014-00036
Event Type
Injury
Date Received
August 19, 2014
Date of Event
May 22, 2014
Report Date
July 2, 2014
Manufacturer
SORIN GROUP CANADA
Product Code
LWR
PMA / PMN Number
P060038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE PATHOLOGY ANALYSIS ON THE VALVE IS STILL ONGOING. NO FINAL EVALUATION CAN BE DRAWN.

Description of Event or Problem · 1

THE MANUFACTURER WAS NOTIFIED ON (B)(6) 2014 THAT A MITROFLOW VALVE MODEL LXA SIZE 25 WAS EXPLANTED IN A JUVENILE PATIENT AFTER 1.5 YEARS DUE TO REGURGITATION. THE MITROFLOW AORTIC VALVE WAS EXPLANTED FROM THE PULMONARY POSITION. IT WAS ALSO NOTIFIED THAT DURING THE SAME SURGERY ANOTHER MITROFLOW VALVE MODEL LXA SIZE 23 IMPLANTED IN THE AORTIC POSITION WAS EXPLANTED DUE TO AORTIC STENOSIS ( THE MANUFACTURER SUBMITTED AND MDD ALSO FOR THIS EVENT 3004478276-2014-00035).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
496673 MITROFLOW AORTIC PERICARDIAL HEART VALVE MITROFLOW LWR SORIN GROUP CANADA LXA

Patients

Seq Age Sex Outcome Treatment
1 14 YR Male Hospitalization| R